openPR Logo
Press release

Kidney Dialysis Equipment Market to be Surpass US$ 29.9 Billion by 2027 | Fresenius Medical Care AG & Co, Baxter International, Inc., Nipro Corporation

08-12-2020 02:13 PM CET | Health & Medicine

Press release from: Coherent Market Insights (CMI)

Kidney Dialysis Equipment Market

Kidney Dialysis Equipment Market

Global Kidney Dialysis Equipment Market, by Equipment (Hemodialysis (Hemodialysis Machines and Consumables), Peritoneal Dialysis (Peritoneal Dialysis Machines and Consumables), and Continuous Renal Replacement Therapy (CRRT)), by End User (Home Care Settings, Dialysis Centers, and Hospitals & Clinics), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 16,874.5 mn in 2018, and is expected to exhibit a CAGR of 6.6% over the forecast period (2019–2027).

Increasing demand of kidney dialysis equipments by hospitals is expected to drive the global kidney dialysis equipment market growth Increasing adoption of kidney dialysis equipment by hospitals and clinics is expected to increase demand for dialysis equipment, which is expected to drive growth of the global kidney dialysis equipment market over the forecast period.

Request a sample report: https://www.coherentmarketinsights.com/insight/request-sample/222

For instance, in August 2019, Narayana Health Hospital (India) adopted several dialysis equipment and apparatus to offer services with several treatment options for patients suffering from end-stage renal diseases (ESRD), which require dialysis (hemodialysis or peritoneal dialysis) or kidney transplantation. ESRD can be treated by using dialysis equipment and apparatus such as dialyzer, tube for transfer of blood and dialysis solution, and hemodialysis machine.

Increasing product launches is expected to boost the global kidney dialysis equipment market growth Increasing demand of dialysis equipments has influenced manufacturers to launch new dialysis equipment with home care services for patients. For instance, in July 2019, Fresenius Medical Care Korea, launched Sleep Safe Harmony, an automatic peritoneal dialysis device. This device help patients with peritoneal dialysis by performing all treatment procedures at home. High chronic kidney disease (CKD) prevalence is expected to increase demand of treatment such as dialysis procedure, which is expected to propel the global kidney dialysis equipment market growth.

Increasing prevalence of kidney diseases has led to increased demand of dialysis. Low availability of kidney donors has resulted in increasing demand for kidney dialysis equipment. For instance, according to the National Kidney Foundation (NKF) in U.S. more than 100,000 patients required kidney transplant in 2018, of which only 21,167 received one kidney from donors (among overall donors 1/3rd of kidneys were donated from living kidney donors). According to same source, (NKF) in the U.S. about 12 people die every day while waiting for a kidney transplant. The demand for kidney donors in the U.S. is increasing by 8% annually.

Globally, Taiwan, U.S., Japan, Mexico, and Belgium are the countries with highest prevalence of ESRD. Kidney disease is the ninth-leading cause of death in the U.S. For instance, according to the American Kidney Fund, in 2015, around 31 million people in the U.S. (10% of the adult population) suffered from the chronic kidney disease (CKD). According to the same source 50% of men suffering from chronic kidney disease have higher chances of developing kidney failure, also known as end-stage renal disease (ESRD).

Download PDF brochure of this report: https://www.coherentmarketinsights.com/insight/request-pdf/222

Major players operating in the global kidney dialysis equipment market include Baxter International, Inc., Fresenius Medical Care AG & Co., Nipro Corporation, B. Braun Melsungen, Nikkiso Co, Ltd., Asahi Kasei Corporation, NxStage Medical, Inc, Guangdong BioLight Meditech Co., Ltd, Dialife SA, and DaVita Inc.

Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Kidney Dialysis Equipment Market to be Surpass US$ 29.9 Billion by 2027 | Fresenius Medical Care AG & Co, Baxter International, Inc., Nipro Corporation here

News-ID: 2110732 • Views: 387

More Releases from Coherent Market Insights (CMI)

Upcomeing Trend of the oncology biosimilars market over the forecast to 2026 | A …
In approval of first biosimilars in two key markets, Europe and the U.S. First biosimilar was approved in 2006 in Europe, however, in the U.S. first product was approved in 2015. But since approving the first biosimilar, the FDA has approved five products in 2017. Out of these five biosimilars, two were approved for oncology. First, oncology biosimilar Mvasi (bevacizumab-awwb) received approval in September 2017, and second one, Ogivri (trastuzumab)
Increasing Drug Approvals Are Attributing To The Highest Share Of North America …
Regional oncology drugs market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America oncology drugs market holds dominant position in the global oncology drugs market. Advanced medical treatment options available for cancer in economies such as the U.S. and increasing survival rate are key factors driving the market growth. For instance, according to the American Association for Cancer Research’s 2015 report, the number
Plant-based Vaccines Market - Research & Development (R&D) Activities | Medicago …
Plant-based vaccines market are focused on extensive clinical trial studies to develop plant-based vaccines for numerous therapeutic applications. For instance, Medicago Inc., a clinical-stage biotechnology company, which uses plant-based technologies to develop and produce novel vaccine and antibodies, is cultivating several tobacco plants (Nicotiana tabacum) at Durham's Research Triangle Park, North America, which will be used in testing and production of the flu vaccine. In March 2018, Medicago conducted phase
Cervical Cancer Drugs Market - Size, Share, Outlook, and Opportunity Analysis, 2 …
Increasing funding for cancer research, rising insurance coverage, and increase in the number of new targeted cancer drugs are expected to support the revenue growth of cervical cancer drugs market. For instance, National Cancer Institute, in 2015, spent around US$ 4,480 million on cancer research, which include cervical cancer, lung cancer, colorectal cancer, liver cancer, breast cancer, leukaemia, ovarian cancer, and uterine cancer. Furthermore, according to the American Cancer Society,

All 5 Releases


More Releases for Kidney

Global Kidney Detox Market Research Report
This report studies the global Kidney Detox market status and forecast, categorizes the global Kidney Detox market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Monster Nutrition(US) Nutrionn(US) Nusapure(US) Thrive Naturals(US) Lally Naturals(US) NOW Foods(US) ReNew Life Formulas, Inc.(USA) Nutracraft(US) American Botanical
Kidney Care Specialists Launch Regional Information Website
Redesigned Kidney Care of Michiana Website Provides Access to Multiple Trusted Resources on Kidney Disease, Dialysis, and Hypertension with Dietary Guidelines Mishawaka, IN; November 1, 2018 – Kidney Care of Michiana has announced the launch of a completely redesigned website with expanded content and providing authoritative information on kidney disease, dialysis and hypertension along with appropriate dietary guidelines via some 40 links available from the new website
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for
3rd Annual Kidney Congress
On behalf of the Conference Series LLC Ltd and the Organizing committee of Kidney 2018, we are pleased to welcome you to participate in the 3rd Annual Kidney Congress. The conference will be held from October 19 - 20, 2018 in New York, USA Major scientific sessions: Kidney Fluid, Electrolytes, Acid-Base Disorders Acute Kidney Injury (AKI) CKD -Mineral and Bone Disorders Chronic Kidney Disease (CKD) Kidney and Bladder stones Dialysis and Renal Care Urology/Urinary Tract Infections Kidney Transplantation Geriatric-Genetic Kidney
Asia-Pacific Kidney Detox Market Report 2018
Worldwide Market Reports added Latest Research Report titled “Asia-Pacific Kidney Detox Market Report 2018” In this report, the Asia-Pacific Kidney Detox market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (Units), revenue (Million USD), market share and growth
Kidney Cancer Drugs Market Growth Analysis 2020
A report by Transparency Market Research predicts the global market for kidney cancer drugs to expand at a 6.6% CAGR during the period between 2014 and 2020.   The global kidney cancer drugs market is dominated by a few global giants, namely F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, GlaxoSmithKline plc, and Pfizer, Inc. This makes the competitive landscape highly consolidated in nature. Competition among the players is stiff